Twist Bioscience (TWST) Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Non-Current Assets for 9 consecutive years, with $351.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 15.57% year-over-year to $351.1 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 23.37% increase from a year earlier, with the FY2025 full-year figure at $308.9 million, up 15.45% from the prior year.
• Non-Current Assets was $351.1 million for Q2 2026 at Twist Bioscience, roughly flat from $352.8 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $368.1 million in Q4 2022 and troughed at $257.2 million in Q1 2025.
• A 5-year average of $328.7 million and a median of $346.9 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 415.6% in 2022 and decreased 24.26% in 2024, its largest moves.
• Over 5 years, Non-Current Assets stood at $368.1 million in 2022, then dropped by 6.93% to $342.6 million in 2023, then retreated by 23.15% to $263.3 million in 2024, then advanced by 26.94% to $334.2 million in 2025, then climbed by 5.07% to $351.1 million in 2026.
• The last three Non-Current Assets figures came in at $351.1 million (Q2 2026), $352.8 million (Q1 2026), and $334.2 million (Q4 2025), per Business Quant data.